KJKenji Jinnai

Kenji Jinnai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kenji Jinnai has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Itaru Funakawa

    Department of Neurology National Hospital Organization Hyogo‐Chuo Hospital 1314 Ohara Sanda 669‐1592 Japan

    3 shared publications
  • Kyoko Itoh

    Department of Pathology and Applied Neurobiology Kyoto Prefectural University of Medicine Kyoto Japan

    2 shared publications
  • Naonobu Futamura

    Department of Neurology National Hospital Organization Hyogo‐Chuo Hospital 1314 Ohara Sanda 669‐1592 Japan

    2 shared publications
  • Akira Tamaoka

    Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennoudai, Tsukuba, Ibaraki 305-8575, Japan

    1 shared publication
  • Atsushi Kuga

    Department of Neurology, National Hospital Organization Hyogo Chuo National Hospital

    1 shared publication
  • Hiroshi Itoh

    First Department of Pathology, Kobe University School of Medicine, Kobe and

    1 shared publication

Latest Publications

  • Open Access

    LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains

    by Jun-Ichi Satoh, Nobutaka Motohashi, Yoshihiro Kino, Tsuyoshi Ishida, Saburo Yagishita, Kenji Jinnai, Nobutaka Arai, Kiyotaka Nakamagoe, Akira Tamaoka, Yuko Saito, et al.

    Nasu-Hakola disease (NHD) is a rare autosomal recessive disorder characterized by sclerosing leukoencephalopathy and multifocal bone cysts, caused by a loss-of-function mutation of either DAP12 or TREM2. TREM2 and DAP12 constitute a receptor/adaptor signaling complex expressed exclusively on osteoclasts, dendritic cells, macrophages, and microglia. Neuropathologically, NHD exhibits profound loss of myelin and accumulation of axonal spheroids, accompanied by intense gliosis accentuated in the white matter of the frontal and temporal lobes. At present, the molecular mechanism responsible for development of leukoencephalopathy in NHD brains remains totally unknown.


  • Somatic instability of CTG repeats in the cerebellum of myotonic dystrophy type 1

    by Kenji Jinnai, Maki Mitani, Naonobu Futamura, Kunihiko Kawamoto, Itaru Funakawa, Kyoko Itoh

    Introduction: We statistically analyzed somatic instability of the CTG expansion in the central nervous system and visceral organs in 7 patients with myotonic dystrophy type 1 and also report intracerebellar instability in 2 patients. Methods: CTG repeat expansion was estimated in the samples from autopsied brains and visceral organs by Southern blot analysis. Pathological study was performed. Samples were taken from several sites in the cerebellum to examine intracerebellar instability. Results: The CTG repeat expansion was shortest in the cerebellar cortex among all tissues examined. With regard to the intracerebellar difference, the shortest expansion was seen in the cortices of the hemisphere and vermis, whereas it was moderate in the dentate nucleus and longest in the white matter of the hemisphere and middle cerebellar peduncle. Conclusions: The shortest expansion might be attributable to packed granule cells in the cerebellar cortex. Further analysis of cell‐specific methylation states might elucidate the enigma of somatic instability. Muscle Nerve, 2013


    • 1 October 2004
      • Vol. 44  (10) , 691-4

    [Allergic skin rashes by methylprednisolone in a case with multiple sclerosis].

    by Atsushi Kuga, Naonobu Futamura, Itaru Funakawa, Kenji Jinnai

    We reported a 34-year-old woman with multiple sclerosis showing an allergic reaction to methylprednisolone sodium succinate. She was admitted to our hospital with a complaint of hypesthesia in the right side of the face and body. MRI showed several high signal intensity lesions in her brain with Gd-DTPA enhancement effect. She was diagnosed as having an acute relapse of MS from previous episodes and clinical findings. We started a methylprednisolone pulse therapy. After the injection on the first day, skin rashes appeared on her trunk and thigh. On the second day, the skin rashes spread over her whole body. Patch test for methylprednisolone sodium succinate (MP) was positive. The steroid administration was substituted by intravenous injections of betamethasone 100mg/day for three days. Her neurological and radiological findings were successfully disappeared without any side effects. This case indicates the efficacy of substitution therapy of betamethasone for MP.

    • 1 September 2004
      • Vol. 44  (9) , 639-42

    [Cortical reflex myoclonus in adult onset Huntington's disease].

    by Itaru Funakawa, Kenichi Kimura, Kenji Jinnai

    We report a case of cortical reflex myoclonus in adult onset Huntington's disease (HD). The patient is a 51-year-old woman. Chorea and myoclonus were observed on her face and extremities. Neurophysiological tests showed C reflex and abnormal waves preceding myoclonus by jerk-locked back averaging method but no giant somatosensory evoked potential. Gene analysis revealed the prolongation of CAG repeats (13/44) in IT15 gene. Oral administration of clonazepam was transiently effective for myoclonus. We should inscribe that the cortical reflex myoclonus may exceptionally manifest in HD.


  • Multifocal glial nodules in a case of Duchenne muscular dystrophy with severe mental retardation

    by Kyoko Itoh, Kenji Jinnai, Kazuo Tada, Kiyokazu Hara, Hiroshi Itoh, Keiichi Takahashi